- Популярные видео
- Авто
- Видео-блоги
- ДТП, аварии
- Для маленьких
- Еда, напитки
- Животные
- Закон и право
- Знаменитости
- Игры
- Искусство
- Комедии
- Красота, мода
- Кулинария, рецепты
- Люди
- Мото
- Музыка
- Мультфильмы
- Наука, технологии
- Новости
- Образование
- Политика
- Праздники
- Приколы
- Природа
- Происшествия
- Путешествия
- Развлечения
- Ржач
- Семья
- Сериалы
- Спорт
- Стиль жизни
- ТВ передачи
- Танцы
- Технологии
- Товары
- Ужасы
- Фильмы
- Шоу-бизнес
- Юмор
FDA Decision Incoming for Game Changing Drug vepdegestrant
ig update in breast cancer treatment! Arvinas and Pfizer’s drug vepdegestrant just had its New Drug Application accepted by the FDA for patients with ER+/HER2-, ESR1-mutated advanced breast cancer who’ve already tried endocrine therapy. The FDA decision date? June 5, 2026.
⚠️ This video contains AI-generated voiceover for informational purposes. No real individuals are speaking.
Видео FDA Decision Incoming for Game Changing Drug vepdegestrant канала ClinOrbit
⚠️ This video contains AI-generated voiceover for informational purposes. No real individuals are speaking.
Видео FDA Decision Incoming for Game Changing Drug vepdegestrant канала ClinOrbit
Комментарии отсутствуют
Информация о видео
11 августа 2025 г. 17:27:09
00:00:54
Другие видео канала
FDA Clears IND for New Bispecific Antibody AXN 2510 for Solid Tumors!
FDA approved ANZUPGO® delgocitinib cream 20 mgg for moderate to severe chronic hand eczema CHE
FDA has accepted and granted Priority Review for tabelecleucel
BREAKING in Cancer Research- Orphan Drug Designation for BP2202
FDA Approves EKTERLY® (sebetralstat)-First Oral On-Demand Treatment for Hereditary Angioedema!
New Hope for Lung Cancer: China Approves ORPATHYS & TAGRISSO Combo
Deramiocel BLA Update: Capricor & FDA
FDA Approves SIR-Spheres® Y-90 for Liver Cancer!
sNDA for toripalimab + disitamab vedotin as 1L HER2 expressing urothelial carcinoma
Corcept Files NDA for Ovarian Cancer Drug Relacorilant!
PAH Breakthrough: Winrevair Gets FDA Priority Review
Orphan Drug Status to a potential breakthrough treatment — SPG601 from Spinogenix!
sNDA submitted to U S FDA for CAPLYTA® lumateperone
Big leap in kidney disease treatment!IND for PS-002 approved by FDA for IgAN
FDA granted Orphan Drug Designation to Mustang Bio’s MB-101 to Treat Astrocytomas and Glioblastoma
ENHERTU plus pertuzumab: Granted Breakthrough Therapy Designation by the U.S. FDA!
U S FDA approved an expanded indication for AJOVY® fremanezumab vfrm for episodic migraine
Swissmedic has approved IFINWIL® for paediatric patients with high-risk neuroblastoma
IXCHIQ® Cleared for Elderly Use in EU!
U S FDA granted accelerated approval to Boehringer Ingelheim’s HERNEXEOS® zongertinib
European Commission Approved TEVIMBRA tislelizumab for Nasopharyngeal Carcinoma
